Apollo Hospitals Enterprise Limited
NSE: APOLLOHOSP BSE: APOLLOHOSP
Prev Close
7005.5
Open Price
7038
Volume
533,342
Today Low / High
7000 / 7092
52 WK Low / High
5693.2 / 7545.35
Range
6,720 - 7,427
Prev Close
7002.2
Open Price
7007.05
Volume
2,202
Today Low / High
7003 / 7088.85
52 WK Low / High
5690.8 / 7545.1
Range
6,719 - 7,427
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 7073.5 (target range: 6,720 - 7,427), reflecting a change of 68 (0.97067%). On the BSE, it is listed at 7073 (target range: 6,719 - 7,427), showing a change of 70.8 (1.01111%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Apollo Hospitals Enterprise Limited Graph
Apollo Hospitals Enterprise Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Apollo Hospitals Enterprise Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 7,073.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 7,073.00 | 7,143.73 | 6,429.36 - 7,858.10 |
7,214.46 | 5,771.57 - 8,657.35 | ||
7,285.19 | 5,099.63 - 9,470.75 | ||
Bearish Scenario | 7,073.00 | 7,002.27 | 6,302.04 - 7,702.50 |
6,931.54 | 5,545.23 - 8,317.85 | ||
6,860.81 | 4,802.57 - 8,919.05 |
Overview of Apollo Hospitals Enterprise Limited
ISIN
INE437A01024
Industry
Medical - Care Facilities
Vol.Avg
406,560
Market Cap
1,017,063,197,500
Last Dividend
19
Official Website
IPO Date
2002-07-01
DCF Diff
-234.11
DCF
7,308
Financial Ratios Every Investor Needs
Stock Dividend of APOLLOHOSP
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2025-02-14 | February 14, 25 | 9 | 9 | 2025-02-15 | 2025-02-28 | |
2024-08-16 | August 16, 24 | 10 | 10 | 2024-08-17 | 2024-09-09 | |
2024-02-20 | February 20, 24 | 6 | 6 | 2024-02-20 | 2024-03-06 | |
2023-08-18 | August 18, 23 | 9 | 9 | 2023-08-19 | 2023-09-27 | |
2023-02-24 | February 24, 23 | 6 | 6 | 2023-02-24 | 2023-03-10 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 19,059.20 Cr | 15,570.70 Cr | 3,488.50 Cr | 0.1830 | 23.40 Cr | 1,894.70 Cr | 1,707.30 Cr | 898.60 Cr | 62.50 | 2,402.00 Cr | 0.0471 |
2023-03-31 | 16,612.45 Cr | 8,574.23 Cr | 8,038.22 Cr | 0.4839 | 21.10 Cr | 1,492.90 Cr | 1,449.20 Cr | 819.10 Cr | 56.97 | 2,139.30 Cr | 0.0493 |
2022-03-31 | 14,536.20 Cr | 7,573.50 Cr | 6,962.70 Cr | 0.4790 | 11.00 Cr | 1,219.10 Cr | 1,588.40 Cr | 1,055.60 Cr | 73.42 | 2,556.80 Cr | 0.0726 |
2021-03-31 | 10,468.00 Cr | 5,684.20 Cr | 4,783.80 Cr | 0.4570 | 0.00 Cr | 718.30 Cr | 567.20 Cr | 150.40 Cr | 10.74 | 1,242.40 Cr | 0.0144 |
2020-03-31 | 11,171.50 Cr | 5,498.90 Cr | 5,672.60 Cr | 0.5078 | 0.00 Cr | 804.90 Cr | 971.30 Cr | 454.90 Cr | 32.69 | 1,811.90 Cr | 0.0407 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 505.50 Cr | 16,753.10 Cr | 9,432.60 Cr | 6,935.4000 Cr | 5,332.60 Cr | 4,827.10 Cr | 459.80 Cr | 9,385.20 Cr | 135.60 Cr | 0.00 Cr | 356.70 Cr | 4,664.5000 Cr |
2023-03-31 | 433.42 Cr | 14,427.73 Cr | 7,896.45 Cr | 6,197.1400 Cr | 4,332.36 Cr | 3,898.94 Cr | 390.19 Cr | 8,033.73 Cr | 275.03 Cr | 673.62 Cr | 414.50 Cr | 3,324.8000 Cr |
2022-03-31 | 583.00 Cr | 13,192.40 Cr | 7,314.70 Cr | 5,623.3000 Cr | 4,068.10 Cr | 3,485.10 Cr | 431.90 Cr | 7,279.20 Cr | 408.00 Cr | 622.00 Cr | 390.10 Cr | 2,383.3000 Cr |
2021-03-31 | 425.20 Cr | 11,416.70 Cr | 6,614.30 Cr | 4,602.5000 Cr | 4,159.70 Cr | 3,734.50 Cr | 249.50 Cr | 6,545.80 Cr | 372.10 Cr | 612.40 Cr | 344.90 Cr | 2,037.8000 Cr |
2020-03-31 | 380.70 Cr | 11,338.40 Cr | 7,868.60 Cr | 3,339.1000 Cr | 5,620.70 Cr | 5,240.00 Cr | 737.80 Cr | 7,260.90 Cr | 338.80 Cr | 517.40 Cr | 359.20 Cr | 2,337.3000 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31 | 1,920.2000 Cr | -1,537.2000 Cr | -311.1000 Cr | 783.4000 Cr | 72.1000 Cr | 505.5000 Cr | -1,136.8000 Cr | 898.6000 Cr | 224.6000 Cr | -215.7000 Cr | -69.2000 Cr |
2023-03-31 | 1,377.0500 Cr | -870.6100 Cr | -633.3300 Cr | 248.5300 Cr | -113.1300 Cr | 433.4200 Cr | -1,128.5200 Cr | 844.5700 Cr | 68.8000 Cr | -255.2000 Cr | 41.9300 Cr |
2022-03-31 | 1,628.0000 Cr | -778.2000 Cr | -792.6000 Cr | 970.8000 Cr | 157.8000 Cr | 583.0000 Cr | -657.2000 Cr | 1,108.4000 Cr | -493.1000 Cr | -43.3000 Cr | -175.8000 Cr |
2021-03-31 | 1,273.4000 Cr | -872.3000 Cr | -340.1000 Cr | 977.9000 Cr | 44.5000 Cr | 425.2000 Cr | -295.5000 Cr | 136.8000 Cr | -898.5000 Cr | -38.3000 Cr | -94.6000 Cr |
2020-03-31 | 1,292.8000 Cr | -288.8000 Cr | -909.5000 Cr | 779.8000 Cr | 94.5000 Cr | 380.7000 Cr | -513.0000 Cr | 431.7000 Cr | -186.0000 Cr | -155.1000 Cr | -153.1000 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2024-12-31 | 5,526.90 Cr | 2,900.70 Cr | 2,626.20 Cr | 0.4752 | 576.90 Cr | 372.30 Cr | 25.89 | 830.60 Cr | 0.0674 |
2024-09-30 | 5,589.30 Cr | 2,857.70 Cr | 2,731.60 Cr | 0.4887 | 631.00 Cr | 378.80 Cr | 26.34 | 859.40 Cr | 0.0678 |
2024-06-30 | 5,085.60 Cr | 3,458.50 Cr | 1,627.10 Cr | 0.3199 | 497.70 Cr | 305.20 Cr | 21.23 | 712.30 Cr | 0.0600 |
2024-03-31 | 4,943.90 Cr | 3,380.30 Cr | 1,563.60 Cr | 0.3163 | 450.80 Cr | 253.80 Cr | 17.65 | 668.60 Cr | 0.0513 |
2023-12-31 | 4,850.60 Cr | 2,533.10 Cr | 2,317.50 Cr | 0.4778 | 475.90 Cr | 245.30 Cr | 17.06 | 641.50 Cr | 0.0506 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2024-09-30 | 1,435.30 Cr | 2,008.70 Cr | 3,444.00 Cr | 0.00 Cr | 448.20 Cr | 7,338.20 Cr | 10,084.40 Cr | 19,547.90 Cr | 11,633.30 Cr |
2024-06-30 | 0.00 Cr | 0.00 Cr | 1,189.50 Cr | 0.00 Cr | 0.00 Cr | 1,189.50 Cr | 0.00 Cr | 0.00 Cr | -7,320.50 Cr |
2024-03-31 | 933.80 Cr | 684.00 Cr | 1,617.80 Cr | 2,818.00 Cr | 459.80 Cr | 5,279.70 Cr | 9,385.20 Cr | 16,753.10 Cr | 9,432.60 Cr |
2023-12-31 | -1,431.40 Cr | 2,862.80 Cr | 1,431.40 Cr | 0.00 Cr | 0.00 Cr | 1,431.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-09-30 | 472.40 Cr | 1,089.40 Cr | 1,561.80 Cr | 2,549.90 Cr | 423.40 Cr | 4,887.80 Cr | 8,498.70 Cr | 15,560.90 Cr | 8,683.30 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2024-06-30 | 305.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-03-31 | 253.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-12-31 | 245.30 Cr | 334.00 Cr | 0.00 Cr | 0.00 Cr | 334.00 Cr | 1,203.00 Cr | 869.00 Cr | 0.00 Cr | 334.00 Cr |
2023-09-30 | 232.90 Cr | 326.80 Cr | 0.00 Cr | 0.00 Cr | 326.80 Cr | 869.00 Cr | 542.20 Cr | 0.00 Cr | 326.80 Cr |
2023-06-30 | 166.60 Cr | 29.20 Cr | 0.00 Cr | 0.00 Cr | -675.50 Cr | 29.20 Cr | 704.70 Cr | 0.00 Cr | 29.20 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
2010-09-02 | September 02, 10 | 2:1 |
Similar Stocks: Medical - Care Facilities
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Max Healthcare Institute Limited | MAXHEALTH | ₹1,084.40 | ₹1,054,190,784,800.00 | ₹2,992,408.00 |
Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,073.50 | ₹1,017,063,197,500.00 | ₹533,342.00 |
Fortis Healthcare Limited | FORTIS | ₹664.55 | ₹501,707,405,355.00 | ₹1,737,166.00 |
Narayana Hrudayalaya Limited | NH | ₹1,854.40 | ₹378,967,038,400.00 | ₹1,248,085.00 |
Global Health Limited | MEDANTA | ₹1,269.10 | ₹340,864,231,267.00 | ₹277,810.00 |
Krishna Institute of Medical Sciences Limited | KIMS | ₹654.55 | ₹261,910,949,723.00 | ₹375,350.00 |
Aster DM Healthcare Limited | ASTERDM | ₹499.50 | ₹249,506,773,470.00 | ₹547,108.00 |
Rainbow Children's Medicare Limited | RAINBOW | ₹1,503.20 | ₹152,652,476,357.00 | ₹102,839.00 |
HealthCare Global Enterprises Limited | HCG | ₹593.45 | ₹82,735,831,750.00 | ₹255,273.00 |
Artemis Medicare Services Limited | ARTEMISMED | ₹278.70 | ₹38,711,430,000.00 | ₹77,487.00 |
Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹421.25 | ₹38,617,251,250.00 | ₹183,221.00 |
Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
Gender: female
Year Born: 1982
Gender: Not Specified
Year Born: 1957
Gender: male
Year Born: 1952
Gender: male
Year Born: 1969
Gender: male
Year Born: 1975
Gender: female
Year Born: 1959
Gender: Not Specified
Year Born: 1962
Gender: male
Year Born: 1955
Gender: Not Specified
Year Born: 1932
Gender: male
Year Born: 1969
FAQs about Apollo Hospitals Enterprise Limited
The CEO is Dr. Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS.
The current price is ₹7,073.50.
The range is ₹5693.2-7545.35.
The market capitalization is ₹101,706.32 crores.
The dividend yield is 0.27%.
The P/E ratio is 77.64.
The company operates in the Healthcare sector.
Overview of Apollo Hospitals Enterprise Limited (ISIN: INE437A01024) is a leading Medical - Care Facilities in India. With a market capitalization of ₹101,706.32 crores and an average daily volume of 406,560 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹19.